Swedbank AB Has $3.67 Million Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Swedbank AB decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 27.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 410,066 shares of the pharmacy operator's stock after selling 153,573 shares during the quarter. Swedbank AB's holdings in Walgreens Boots Alliance were worth $3,674,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in WBA. Scientech Research LLC acquired a new position in shares of Walgreens Boots Alliance in the second quarter worth about $1,215,000. Ariel Investments LLC raised its stake in shares of Walgreens Boots Alliance by 10.8% in the 2nd quarter. Ariel Investments LLC now owns 2,038,878 shares of the pharmacy operator's stock valued at $24,660,000 after purchasing an additional 198,891 shares in the last quarter. Exchange Traded Concepts LLC acquired a new stake in Walgreens Boots Alliance during the third quarter valued at approximately $795,000. Clifford Capital Partners LLC lifted its holdings in Walgreens Boots Alliance by 58.4% during the 2nd quarter. Clifford Capital Partners LLC now owns 803,204 shares of the pharmacy operator's stock worth $9,715,000 after buying an additional 296,135 shares during the last quarter. Finally, Cetera Investment Advisers grew its position in shares of Walgreens Boots Alliance by 89.8% in the 1st quarter. Cetera Investment Advisers now owns 349,464 shares of the pharmacy operator's stock worth $7,580,000 after acquiring an additional 165,389 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on WBA. Royal Bank of Canada reduced their price target on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a "sector perform" rating on the stock in a research report on Tuesday, July 2nd. JPMorgan Chase & Co. decreased their price target on Walgreens Boots Alliance from $20.00 to $15.00 and set an "overweight" rating for the company in a research note on Friday, August 30th. Bank of America reduced their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an "underperform" rating for the company in a report on Wednesday, September 4th. UBS Group boosted their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a "neutral" rating in a research report on Thursday. Finally, Morgan Stanley decreased their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating for the company in a report on Friday, October 11th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of "Hold" and a consensus target price of $13.38.

Walgreens Boots Alliance Trading Up 1.2 %

WBA traded up $0.13 during trading on Friday, reaching $10.79. The company had a trading volume of 21,827,279 shares, compared to its average volume of 17,152,635. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. Walgreens Boots Alliance, Inc. has a 12-month low of $8.22 and a 12-month high of $27.05. The company has a market cap of $9.31 billion, a price-to-earnings ratio of -1.60, a PEG ratio of 1.06 and a beta of 0.70. The firm's 50-day simple moving average is $9.41 and its 200 day simple moving average is $13.10.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.03. The firm had revenue of $37.50 billion during the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company's revenue was up 5.9% on a year-over-year basis. During the same quarter last year, the business posted $0.67 EPS. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.85 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.